Literature DB >> 348297

Cytology and colchicine sensitivity of viable cells from lymph nodes with malignant lymphoma.

R Schrek, Z Molnar, S S Stefani.   

Abstract

Viable cell suspensions were prepared from 31 nodes diagnosed non-Hodgkin's malignant lymphoma, and from 30 non-malignant nodes. The cells were examined and counted by phase contrast microscopy. The suspensions were characterized by the percentage of large cells and by a colchicine-sensitivity index. The finding of more than 6% large cells or the finding of a sensitivity index of more than 30% was considered a positive test for a malignant lymphoma. According to these criteria there were 2 false positives in 30 reactive nodes and one false negative in 31 malignant nodes. Findings on 3 nodes diagnosed angioimmunoblastic lymphadenopathy suggested malignancy. The colchicinesensitivity index of blood lymphocytes seemed useful for monitoring lymphoma patients for leukemic involvement.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 348297     DOI: 10.1002/1097-0142(197805)41:5<1845::aid-cncr2820410528>3.0.co;2-2

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

1.  Colchicine in refractory chronic lymphocytic leukemia. A Southwest Oncology Group study.

Authors:  J K Weick; R B Livingston; E J Van Slyck
Journal:  Invest New Drugs       Date:  1983       Impact factor: 3.850

2.  Mouse red cell rosette formation and the colchicine sensitivity test: relative usefulness in the differential diagnosis of chronic lymphocytic leukaemia and B lymphocytic lymphoma.

Authors:  P J Sugden; J S Lilleyman
Journal:  J Clin Pathol       Date:  1982-04       Impact factor: 3.411

3.  Colchicine ultrasensitivity of peripheral-blood lymphocytes from patients with non-Hodgkin's lymphoma.

Authors:  J H Scarffe; J Prudhoe; J V Garrett; D Crowther
Journal:  Br J Cancer       Date:  1980-04       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.